Skip to main content

Bristol Myers Squibb Reports Third Quarter Financial Results for 2025

Bristol Myers Squibb (NYSE: BMY) today reported third quarter 2025 financial results.

Visit the company’s Investor Relations website at http://investor.bms.com to view the detailed third quarter 2025 earnings press release and investor presentation.

The company will host a conference call and live audio webcast for analysts and investors at 8:00 a.m. ET today, October 30, 2025, which is accessible here. Company executives will review financial results with the investment community during the call.

A replay of the webcast will be available at http://investor.bms.com approximately three hours after the conference call concludes.

About Bristol Myers Squibb: Transforming Patients' Lives Through Science

At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com and follow us on LinkedIn, X, YouTube, Facebook and Instagram.

corporatefinancial-news

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  212.35
+2.58 (1.23%)
AAPL  259.18
+3.26 (1.27%)
AMD  220.17
+2.67 (1.23%)
BAC  49.84
+0.45 (0.92%)
GOOG  295.84
+1.38 (0.47%)
META  577.99
+3.52 (0.61%)
MSFT  371.39
-2.07 (-0.55%)
NVDA  177.01
-0.38 (-0.21%)
ORCL  144.41
-1.97 (-1.35%)
TSLA  352.59
-8.00 (-2.22%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.